Daria Mochly-Rosen

Last updated

Daria Mochly-Rosen is a Professor of Chemical and Systems Biology at the Stanford University School of Medicine, where she also holds the George D. Smith Chair for Translational Medicine. [1] She is in addition the founder of Mitoconix Bio, a startup company whose goal is to produce drugs that treat Huntington's disease and other neurodegenerative illnesses. [2] [3] [4]

References

  1. ↑ "Daria Mochly-Rosen". Stanford University . Retrieved 2018-08-12.
  2. ↑ "Neurological therapy co Mitoconix Bio raises $20m". Globes. Retrieved 2017-06-27.
  3. ↑ "California Life Sciences Association (CLSA) Adds Leaders from City of Hope, Stanford to Board of Directors" . Retrieved 2017-02-13.[ permanent dead link ]
  4. ↑ Danney, Micah (2017-07-05). "Israeli startup takes aim at Huntington's disease". The Times of Israel . Retrieved 2018-08-12.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.